Literature DB >> 14522936

Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumors is derived from the same progenitor cells as the teratoma.

David W Brandli1, Thomas M Ulbright, Richard S Foster, Oscar W Cummings, Shaobo Zhang, Christopher J Sweeney, John N Eble, Liang Cheng.   

Abstract

Metastatic mature teratoma is often present in postchemotherapy surgical specimens of lymph nodes from patients with pathological stage II or III testicular germ cell tumors. The stromal cells in these lesions have generally been considered "fibrosis" secondary to the chemotherapy and the necrosis it causes, although the frequent cytological atypia of the stromal cells suggests that they may be neoplastic. We studied 25 patients with pathological stage II or III testicular cancer who were treated with platinum-based chemotherapy followed by surgical resection of retroperitoneal lymph nodes that contained metastatic mature teratoma with "fibrosis" to determine the reactive or neoplastic nature of the stromal cells. We compared the pattern of allelic loss using nine microsatellite DNA markers (D9S177, D9S303, D9S778, D9S171, D12S1015, D1S508, D2S156, D18S46, and D11S903) between the epithelial cells of the teratoma and the cells in the adjacent stroma. A laser capture microdissection technique facilitated preparation of genomic DNA from the epithelial components of teratoma, adjacent stromal cells, and normal lymph node tissue from each patient. Of the 25 patients, loss of heterozygosity was seen at a minimum of one focus in 22 (92%) of the teratoma specimens and 16 (64%) of the adjacent stroma. Of the 16 cases for which the stroma showed loss of heterozygosity, 8 cases showed the identical pattern of allelic loss in the epithelial cells of the adjacent teratoma at all nine DNA loci studied. The remaining eight cases showed similar allelic loss in at least one of the nine DNA loci analyzed. Interestingly, three cases showed loss of heterozygosity in the stroma that was not seen in the matching teratoma specimens. Our results indicate that the stromal cells adjacent to metastatic mature teratoma in postchemotherapy lymph node specimens frequently have genetic abnormalities similar to the metastatic teratoma. Concordant genetic alterations observed in teratoma and stroma suggest that both are derived from the same element of the original germ cell tumor or the same progenitor cell.

Entities:  

Mesh:

Year:  2003        PMID: 14522936

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer.

Authors:  Barbara Domazet; Gregory T Maclennan; Antonio Lopez-Beltran; Rodolfo Montironi; Liang Cheng
Journal:  Int J Clin Exp Pathol       Date:  2008-03-15

2.  Tyrosine kinase inhibitors: Multi-targeted or single-targeted?

Authors:  Fleur Broekman; Elisa Giovannetti; Godefridus J Peters
Journal:  World J Clin Oncol       Date:  2011-02-10

3.  Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma.

Authors:  Liang Cheng; Timothy D Jones; Ryan P McCarthy; John N Eble; Mingsheng Wang; Gregory T MacLennan; Antonio Lopez-Beltran; Ximing J Yang; Michael O Koch; Shaobo Zhang; Chong-Xian Pan; Lee Ann Baldridge
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

4.  Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis.

Authors:  Kevin M Kernek; Thomas M Ulbright; Shaobo Zhang; Steven D Billings; Oscar W Cummings; John D Henley; Helen Michael; Matteo Brunelli; Guido Martignoni; Richard S Foster; John N Eble; Liang Cheng
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

5.  Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate.

Authors:  Ryan P McCarthy; Shaobo Zhang; David G Bostwick; Junqi Qian; John N Eble; Mingsheng Wang; Haiqun Lin; Liang Cheng
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 6.  Testicular cancer.

Authors:  Liang Cheng; Peter Albers; Daniel M Berney; Darren R Feldman; Gedske Daugaard; Timothy Gilligan; Leendert H J Looijenga
Journal:  Nat Rev Dis Primers       Date:  2018-10-05       Impact factor: 52.329

7.  KIT mutations are common in testicular seminomas.

Authors:  Kathleen Kemmer; Christopher L Corless; Jonathan A Fletcher; Laura McGreevey; Andrea Haley; Diana Griffith; Oscar W Cummings; Cecily Wait; Ajia Town; Michael C Heinrich
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.